COMMUNIQUÉS West-GlobeNewswire

Global campaign during 10th annual National Blood Donor Week highlights need for blood

11/06/2018 - 13:00

44,000 blood donors needed across the country by Canada Day OTTAWA, June 11, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services is getting ready to support patients this summer and is inviting Canadians to participate in [...]

Une campagne internationale et la dixième Semaine nationale du don de sang attirent l’attention sur les besoins en sang

11/06/2018 - 13:00

Nous avons besoin de 44 000 donneurs d’ici la fête du Canada OTTAWA, 11 juin 2018 (GLOBE NEWSWIRE) -- Pour pouvoir répondre aux besoins des patients cet été, la Société canadienne du sang invite la population à [...]

International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial

11/06/2018 - 13:00

CARLSBAD, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]

MediWound Completes Enrollment in NexoBrid® U.S. Phase 3 DETECT Study

11/06/2018 - 13:00

Top-line acute data currently expected around year end 2018 YAVNE, Israel, June 11, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to [...]

Neuralstem Awarded Phase I SBIR Contract to Support Research into Neural Stem Cell Therapy for Severe Traumatic Brain Injury

11/06/2018 - 13:00

GERMANTOWN, Md., June 11, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has been awarded a Phase I [...]

Transactions under Novozymes’ stock buyback program

11/06/2018 - 12:59

Please read the full announcement in the attached PDF Attachment 2018_38_Stock_Buybackprogram_EN

Novo Nordisk A/S - Share repurchase programme

11/06/2018 - 12:31

Bagsværd, Denmark, 11 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]

Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual Meeting

11/06/2018 - 12:30

Eravacycline Global Surveillance and TP-6076 Data Also Highlighted WATERTOWN, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing [...]

Dynavax to Present at the William Blair 38th Annual Growth Stock Conference

11/06/2018 - 12:30

BERKELEY, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that Michael Ostrach, Dynavax’s Chief Financial Officer, will present at the William Blair 38th Annual [...]

Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint

11/06/2018 - 12:00

Company to focus on advancing VL-2397 and other pipeline opportunities SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced top-line results from a randomized, double-blind, [...]

Fennec Pharmaceuticals Set to Join Russell 3000 Index

11/06/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., June 11, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX), a specialty pharmaceutical company focused on the development of PEDMARK TM (a unique formulation of [...]

Solon Eiendom ASA : Primary insider notification

11/06/2018 - 10:37

(Oslo, Norway, 11 June 2018) Reference is made to Solon Eiendom ASA's (the "Company") prospectus dated 16 May 2018 (the "Prospectus") for inter alia the subsequent offering (the "Subsequent Offering") of up to 396,040 [...]

Solon Eiendom ASA : Final result of the subsequent offering

11/06/2018 - 10:37

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Summit Therapeutics Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018

11/06/2018 - 08:01

Summit Therapeutics plc ("Summit" or the "Company") Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018 Highlights the Power of the Discuva Platform to Identify Novel Antibiotic Targets Oxford, UK, and [...]

Shire plc : Rule 2.9 Announcement

11/06/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 June 2018 Shire [...]

Saniona plans Phase 2a study for treatment of Hypothalamic Obesity

11/06/2018 - 08:00

PRESS RELEASE June 11, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it plans to initiate a clinical Phase 2a study in the rare eating disorder hypothalamic obesity with its [...]

Motif Bio Announces New Iclaprim Data Presented at ASM Microbe 2018

11/06/2018 - 08:00

Pooled efficacy and safety data from REVIVE Phase 3 trials presented Data also published in peer-reviewed journal, International Journal of Antimicrobial Agents NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc [...]

Sanofi Launches "Action 2018", a Worldwide Employee Stock Purchase Plan

11/06/2018 - 07:02

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Launches "Action 2018", a Worldwide Employee Stock Purchase Plan A plan taking place in almost 80 countries Subscription per five shares entitle the [...]

Sanofi lance « Action 2018 », un plan mondial d'actionnariat salarié

11/06/2018 - 07:02

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi lance « Action 2018 », un plan mondial d'actionnariat salarié Un plan déployé dans près de 80 pays Un abondement de l'entreprise par tranche de [...]